US Drug Recall Register

FDA Drug Recalls

14,801 recalls, newest first

Class II · Moderate risk Terminated

Tinactin

Reason cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Bayer Healthcare Pharmaceuticals Inc. NDC 11523-4162-1 D-0242-2022
Class II · Moderate risk Terminated

Lotrimin AF

Reason cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Bayer Healthcare Pharmaceuticals Inc. NDC 11523-4327-1 D-0241-2022
Class II · Moderate risk Terminated

Lotrimin Af

Reason cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Bayer Healthcare Pharmaceuticals Inc. NDC 11523-0010-2 D-0240-2022
Class II · Moderate risk Terminated

Lotrimin Af

Reason cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Bayer Healthcare Pharmaceuticals Inc. NDC 11523-0010-1 D-0239-2022
Class II · Moderate risk Terminated

Lotrimin Af

Reason cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Bayer Healthcare Pharmaceuticals Inc. NDC 11523-0544-2 D-0238-2022
Class II · Moderate risk Terminated

Lotrimin Af

Reason cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Bayer Healthcare Pharmaceuticals Inc. NDC 11523-4140-2 D-0237-2022
Class II · Moderate risk Terminated

Lotrimin Af

Reason cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Bayer Healthcare Pharmaceuticals Inc. NDC 11523-1272-2 D-0236-2022
Class II · Moderate risk Terminated

Artesunate for Injection

Reason Lack of Assurance of Sterility: Air filter failed post integrity test leading to a lack of sterility assurance.

Amivas (US), LLC NDC 73607-001-02 D-0002-2022
Class I · High risk Terminated

Glucagon Emergency Kit for Low Blood Sugar

Reason SUBPOTENT DRUG: Vial contained a liquid substance, instead of the expected powder substance. There was also a lack of full drug effect upon administration.

Eli Lilly & Company D-0009-2022
Class II · Moderate risk Terminated

Hydroquinone USP

Reason Finished product specification did not meet USP specifications.

Monarch PCM, LLC NDC 69367-174-01 D-0855-2021
Class II · Moderate risk Terminated

AirDuo Digihaler 232/14

Reason Subpotent drug: OOS results of Label Claimed Emitted Dose for salmeterol

Teva Pharmaceuticals USA NDC 59310-136-06 D-0025-2022
Class II · Moderate risk Terminated

AirDuo Digihaler 113/14

Reason Subpotent drug: OOS results of Label Claimed Emitted Dose for salmeterol

Teva Pharmaceuticals USA NDC 59310-129-06 D-0024-2022
Class II · Moderate risk Terminated

AirDuo Digihaler 55/14

Reason Subpotent drug: OOS results of Label Claimed Emitted Dose for salmeterol

Teva Pharmaceuticals USA NDC 59310-111-06 D-0023-2022
Class II · Moderate risk Terminated

AirDuo Digihaler 232/14

Reason Subpotent drug: OOS results of Label Claimed Emitted Dose for salmeterol

Teva Pharmaceuticals USA NDC 59310-530-08 D-0022-2022
Class II · Moderate risk Terminated

AirDuo Digihaler 113/14

Reason Subpotent drug: OOS results of Label Claimed Emitted Dose for salmeterol

Teva Pharmaceuticals USA NDC 59310-520-08 D-0021-2022